RAPS workshop on ANDA reviews
Executive SummaryThe Regulatory Affairs Professionals Society workshop Aug. 7-8 in Morristown, N.J. will feature FDA Generic Drugs Div. Director Marvin Seife, MD, and staff, who will present an update on implementation of the ANDA/Patent Restoration Act. Contact: Jean Doherty (202) 857-1148.
You may also be interested in...
Johnson & Johnson has achieved exceptional growth in recent years, and a raft of new products is set to sustain it further.
Bayer’s drive to lead a new market opportunity in Europe for histology-independent cancer agents like Vitrakvi has been set back by interim decisions from the UK’s NICE and Germany’s IQWiG, but there is a now a clear pathway to follow.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.